Skip to main content

Exostoses, Multiple Hereditary clinical trials at UC Health
1 research study open to eligible people

  • An Efficacy and Safety Study of Palovarotene for the Treatment of MO

    open to eligible people ages 2-14

    This is a randomized, double-blind, placebo-controlled study comparing the safety and efficacy of 2 dosage regimens of palovarotene versus placebo in preventing disease progression in pediatric subjects with multiple osteochondromas (MO).

    at UCSF

Last updated: